Lale White, Director at Cardiff Oncology, Inc. (CRDF), bought 15,000 shares at $1.64 ($25K) on 2022-09-19, disclosed to the SEC on 2022-09-20.
Open-market purchase of $25k CRDF by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |